These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15500558)

  • 1. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?
    Lu SN; Tung HD; Chen TM; Lee CM; Wang JH; Hung CH; Chen CH; Changchien CS
    J Viral Hepat; 2004 Nov; 11(6):563-70. PubMed ID: 15500558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
    Pereira FM; Zarife MA; Reis EA; G Reis M
    Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
    Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
    Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
    Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
    J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
    Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
    Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on reliability of commercially available hepatitis C virus antibody tests.
    Feucht HH; Zöllner B; Polywka S; Laufs R
    J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
    Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
    Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
    Cavazza S; Lagging M
    Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
    Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
    Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identified cases of acute hepatitis C from computerized laboratory database: a hospital-based epidemiological and clinical study.
    Hung CH; Lu SN; Wang JH; Hung SF; Chen CH; Hu TH; Lee CM; Changchien CS
    J Infect; 2008 Apr; 56(4):274-80. PubMed ID: 18346790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index.
    Coppola N; Pisapia R; Tonziello G; Masiello A; Martini S; Pisaturo M; Messina V; Sagnelli C; Macera M; Signoriello G; Sagnelli E
    J Clin Virol; 2009 Nov; 46(3):222-9. PubMed ID: 19758839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
    de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
    J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved diagnosis of chronic hepatitis C virus infection by detection of antibody to multiple epitopes: confirmation by antibody to synthetic oligopeptides.
    Brown D; Powell L; Morris A; Rassam S; Sherlock S; McIntyre N; Zuckerman AJ; Dusheiko GM
    J Med Virol; 1992 Nov; 38(3):167-71. PubMed ID: 1283751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-HCV serology for screening, diagnosis and surveillance of hepatitis C: role of the immunoblot].
    Dubois F; Barin F; Goudeau A
    Ann Biol Clin (Paris); 1998; 56(4):417-26. PubMed ID: 9754277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay.
    Lai KK; Jin M; Yuan S; Larson MF; Dominitz JA; Bankson DD
    Clin Chem; 2011 Jul; 57(7):1050-6. PubMed ID: 21566071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.